Skip to main content
Enter the terms you wish to search for.
Select Search Option
This Site
All WCM Sites
Directory
Menu
Weill Cornell Medicine
Care
Discover
Teach
Rubin Lab
Explore this Website
Home
News
About Us
Research
Lab Team
Publications
Resources
Toggle Resources menu options
FISH
Profiler
Tracking Samples
Weill Cornell Medicine
Care
Discover
Teach
Home
News
About Us
Research
Lab Team
Publications
Resources
Home
Publications
Publications
Found 115 results
Author
Title
Type
Year
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
G
Berger MF
,
Lawrence MS
,
Demichelis F
,
Drier Y
,
Cibulskis K
,
Sivachenko AY
,
Sboner A
,
Esgueva R
,
Pflueger D
,
Sougnez C
et al.
. 2011.
The genomic complexity of primary human prostate cancer.
.
Nature. 470(7333):214-20.
Hofer MD
,
Kuefer R
,
Maier C
,
Herkommer K
,
Perner S
,
Demichelis F
,
Paiss T
,
Vogel W
,
Rubin MA
,
Hoegel J
. 2009.
Genome-wide linkage analysis of TMPRSS2-ERG fusion in familial prostate cancer.
.
Cancer Res. 69(2):640-6.
F
Sboner A
,
Habegger L
,
Pflueger D
,
Terry S
,
Chen DZ
,
Rozowsky JS
,
Tewari AK
,
Kitabayashi N
,
Moss BJ
,
Chee MS
et al.
. 2010.
FusionSeq: a modular framework for finding gene fusions by analyzing paired-end RNA-sequencing data.
.
Genome Biol. 11(10):R104.
E
Hofer MD
,
Fecko A
,
Shen R
,
Setlur SR
,
Pienta KG
,
Tomlins SA
,
Chinnaiyan AM
,
Rubin MA
. 2004.
Expression of the platelet-derived growth factor receptor in prostate cancer and treatment implications with tyrosine kinase inhibitors.
.
Neoplasia. 6(5):503-12.
Barbieri CE
,
Baca SC
,
Lawrence MS
,
Demichelis F
,
Blattner M
,
Theurillat J-P
,
White TA
,
Stojanov P
,
Van Allen E
,
Stransky N
et al.
. 2012.
Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer.
.
Nat Genet. 44(6):685-9.
Rubin MA
. 2012.
ETS rearrangements in prostate cancer.
.
Asian J Androl. 14(3):393-9.
Tomlins SA
,
Bjartell A
,
Chinnaiyan AM
,
Jenster G
,
Nam RK
,
Rubin MA
,
Schalken JA
. 2009.
ETS gene fusions in prostate cancer: from discovery to daily clinical practice.
.
Eur Urol. 56(2):275-86.
Setlur SR
,
Mertz KD
,
Hoshida Y
,
Demichelis F
,
Lupien M
,
Perner S
,
Sboner A
,
Pawitan Y
,
Andrén O
,
Johnson LA
et al.
. 2008.
Estrogen-dependent signaling in a molecularly distinct subclass of aggressive prostate cancer.
.
J Natl Cancer Inst. 100(11):815-25.
Perner S
,
Svensson MA
,
Hossain RR
,
Day JR
,
Groskopf J
,
Slaughter RC
,
Jarleborn AR
,
Hofer MD
,
Kuefer R
,
Demichelis F
et al.
. 2010.
ERG rearrangement metastasis patterns in locally advanced prostate cancer.
.
Urology. 75(4):762-7.
Rickman DS
,
Chen Y-B
,
Banerjee S
,
Pan Y
,
Yu J
,
Vuong T
,
Perner S
,
Lafargue CJ
,
Mertz KD
,
Setlur SR
et al.
. 2010.
ERG cooperates with androgen receptor in regulating trefoil factor 3 in prostate cancer disease progression.
.
Neoplasia. 12(12):1031-40.
Lin P-C
,
Chiu Y-L
,
Banerjee S
,
Park K
,
Mosquera JMiguel
,
Giannopoulou E
,
Alves P
,
Tewari AK
,
Gerstein MB
,
Beltran H
et al.
. 2013.
Epigenetic repression of miR-31 disrupts androgen receptor homeostasis and contributes to prostate cancer progression.
.
Cancer Res. 73(3):1232-44.
Perner S
,
Wagner PL
,
Demichelis F
,
Mehra R
,
Lafargue CJ
,
Moss BJ
,
Arbogast S
,
Soltermann A
,
Weder W
,
Giordano TJ
et al.
. 2008.
EML4-ALK fusion lung cancer: a rare acquired event.
.
Neoplasia. 10(3):298-302.
Pauli C
,
Puca L
,
Mosquera JMiguel
,
Robinson BD
,
Beltran H
,
Rubin MA
,
Rao RA
. 2016.
An emerging role for cytopathology in precision oncology.
.
Cancer Cytopathol. 124(3):167-73.
Barbieri CE
,
Chinnaiyan AM
,
Lerner SP
,
Swanton C
,
Rubin MA
. 2016.
The Emergence of Precision Urologic Oncology: A Collaborative Review on Biomarker-driven Therapeutics.
.
Eur Urol.
Kumar-Sinha C
,
Shah RB
,
Laxman B
,
Tomlins SA
,
Harwood J
,
Schmitz W
,
Conzelmann E
,
Sanda MG
,
Wei JT
,
Rubin MA
et al.
. 2004.
Elevated alpha-methylacyl-CoA racemase enzymatic activity in prostate cancer.
.
Am J Pathol. 164(3):787-93.
Rubin MA
,
Allory Y
,
Molinié V
,
Leroy X
,
Faucon H
,
Vacherot F
,
Huang W
,
Kuten A
,
Salomon L
,
Rebillard X
et al.
. 2005.
Effects of long-term finasteride treatment on prostate cancer morphology and clinical outcome.
.
Urology. 66(5):930-4.
D
Mateo J
,
Carreira S
,
Sandhu S
,
Miranda S
,
Mossop H
,
Perez-Lopez R
,
Rodrigues DNava
,
Robinson D
,
Omlin A
,
Tunariu N
et al.
. 2015.
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer.
.
N Engl J Med. 373(18):1697-708.
Mateo J
,
Boysen G
,
Barbieri CE
,
Bryant HE
,
Castro E
,
Nelson PS
,
Olmos D
,
Pritchard CC
,
Rubin MA
,
de Bono JS
. 2016.
DNA Repair in Prostate Cancer: Biology and Clinical Implications.
.
Eur Urol.
Beltran H
,
Prandi D
,
Mosquera JMiguel
,
Benelli M
,
Puca L
,
Cyrta J
,
Marotz C
,
Giannopoulou E
,
Chakravarthi BVSK
,
Varambally S
et al.
. 2016.
Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer.
.
Nat Med. 22(3):298-305.
Demichelis F
,
Setlur SR
,
Beroukhim R
,
Perner S
,
Korbel JO
,
Lafargue CJ
,
Pflueger D
,
Pina C
,
Hofer MD
,
Sboner A
et al.
. 2009.
Distinct genomic aberrations associated with ERG rearranged prostate cancer.
.
Genes Chromosomes Cancer. 48(4):366-80.
Pflueger D
,
Terry S
,
Sboner A
,
Habegger L
,
Esgueva R
,
Lin P-C
,
Svensson MA
,
Kitabayashi N
,
Moss BJ
,
MacDonald TY
et al.
. 2011.
Discovery of non-ETS gene fusions in human prostate cancer using next-generation RNA sequencing.
.
Genome Res. 21(1):56-67.
Kelly KA
,
Setlur SR
,
Ross R
,
Anbazhagan R
,
Waterman P
,
Rubin MA
,
Weissleder R
. 2008.
Detection of early prostate cancer using a hepsin-targeted imaging agent.
.
Cancer Res. 68(7):2286-91.
Bismar TA
,
Demichelis F
,
Riva A
,
Kim R
,
Varambally S
,
He L
,
Kutok J
,
Aster JC
,
Tang J
,
Kuefer R
et al.
. 2006.
Defining aggressive prostate cancer using a 12-gene model.
.
Neoplasia. 8(1):59-68.
Rubin MA
,
Bismar TA
,
Andrén O
,
Mucci L
,
Kim R
,
Shen R
,
Ghosh D
,
Wei JT
,
Chinnaiyan AM
,
Adami H-O
et al.
. 2005.
Decreased alpha-methylacyl CoA racemase expression in localized prostate cancer is associated with an increased rate of biochemical recurrence and cancer-specific death.
.
Cancer Epidemiol Biomarkers Prev. 14(6):1424-32.
C
Setlur SR
,
Rubin MA
. 2005.
Current thoughts on the role of the androgen receptor and prostate cancer progression.
.
Adv Anat Pathol. 12(5):265-70.
« first
‹ previous
1
2
3
4
(current)
5
next ›
last »